ACCREDITATION STATEMENT
This activity is intended for oncologists, pathologists, obstetricians & gynecologists, radiation oncologists, radiologists, surgeons (including surgical oncologists), primary care physicians (PCPs), internal medicine specialists, nurses/nurse practitioners (NPs), physician assistants (PAs), and pharmacists involved in the care of patients with or at risk of breast cancer
Educational Objectives
Upon completion of the education within the conference, learners will have:
[LIST] [ITEM]Increased knowledge regarding the clinical trial data on therapies, screening, and early detection methods for breast cancer
[ITEM]Greater competence related to
- Tailoring treatment for patients with breast cancer
- Managing treatment-related adverse events that occur in patients with breast cancer
[ITEM]Greater confidence in their ability to communicate effectively and work as part of the interprofessional team to optimize patient care [/LIST]
[JALOGO] In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [bold]Physician Continuing Medical Education [/bold] The Postgraduate Institute for Medicine designates this live activity for a maximum of 12.5 [italic]AMA PRA Category 1 Credits™. [/italic] Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]Continuing Nursing Education [/bold] The maximum number of hours awarded for this Continuing Nursing Education activity is 12.5 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on certificates. [bold]Continuing Pharmacy Education[/bold] PIM designates this continuing education activity for 12.5 contact hours (12.5 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number -JA4008162-9999-23-329-L99-P) Type: Knowledge [bold]Continuing Physician Assistants Education[/bold] AAPA accepts certificates of participation for educational activities certified for [italic]AMA PRA Category 1 Credit™[/italic] from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 12.5 Category 1 credits for completing this activity. [bold]Disclosure of Unlabeled Use[/bold] This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.